Study shows promise of molecular screening for gynecologic cancers, commentary writers state
Wednesday, January 9, 2013 - 20:00
in Health & Medicine
A new study that proposes a three-in-one test for gynecologic cancers underscores the promise of molecular screening for early detection of endometrial and ovarian cancers, but also suggests that such tests are not yet ready for clinical use. Andrea Myers, MD, PhD, of Dana-Farber Cancer Institute, a co-author of the commentary on the study, says the test is an important step in that direction.